APC-0576 is an inhibitor of the NF-κB signaling pathway and can suppress NF-κB-dependent gene activation (IC50 = 1.0 μM for β-galactosidase). It inhibits IL-1-induced chemokine release and is useful for the study of diseases associated with pathological endothelial cell activation.